EI
DGX icon

Ellevest Inc’s Quest Diagnostics DGX Stock Holding History

Ellevest Inc’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-41
Closed -$5K – 1666
2022
Q2 		$5K Hold
41
– – ﹤0.01% 1004
2022
Q1 		$6K Buy
+41
New +$5.71K ﹤0.01% 974
2021
Q3 		– Sell
-9
Closed -$1K – 1443
2021
Q2 		$1K Sell
9
-320
-97% -$41.9K ﹤0.01% 1137
2021
Q1 		$42K Hold
329
– – 0.01% 514
2020
Q4 		$39K Sell
329
-275
-46% -$33.5K 0.01% 513
2020
Q3 		$69K Sell
604
-14
-2% -$1.65K 0.01% 323
2020
Q2 		$70K Buy
618
+88
+17% +$9.33K 0.02% 303
2020
Q1 		$43K Buy
530
+45
+9% +$4.66K 0.01% 258
2019
Q4 		$52K Buy
485
+480
+9,600% +$50.1K 0.01% 183
2019
Q3 		$1K Buy
+5
New +$513 ﹤0.01% 382

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ellevest Inc's DGX Position: Q3 2022 in Review

Ellevest Inc sold out of Quest Diagnostics (DGX) in Q3 2022, closing a stake of 41 shares — an estimated $5K sold.

Ellevest Inc first reported a position in DGX in Q3 2019 and held it in 10 quarters. The position peaked at $70K in Q2 2020. 808 funds tracked by Wall St. Rank hold DGX as of Q3 2022.

  • Ellevest Inc reported no remaining Quest Diagnostics position as of Q3 2022 after selling out during the quarter.
  • Ellevest Inc sold 41 Quest Diagnostics shares in Q3 2022, an estimated $5K.
  • Ellevest Inc first reported a position in Quest Diagnostics in Q3 2019 and held it in 10 quarters.
  • Ellevest Inc's Quest Diagnostics position peaked at $70K in Q2 2020.
  • 808 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2022.

Based on Ellevest Inc's 13F filing for Q3 2022, filed 2 Nov 2022.